ESR1 and breast cancer: In breast cancer models, BAK acts as a selective phytoestrogen, induces S-phase arrest, activates the ATM/ATR-Chk1/Chk2 axis, and triggers mitochondrial apoptosis, particularly in ERα-positive cells.